ERBB2 and breast cancer: On the other hand, 36% of the incidence of bone metastasis is from breast cancer [52], with a tendency of incidence in luminal subtypes (ER+/HER2− 58.52% and in ER+/HER2+ subtype 47.28% of incidence).